Showing results (301-310 of 496) with videos related to

Sort By:
Pageof 50
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 17, 2018
Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort StudyChintan V Dave, Ajinkya Pawar, Erin R Fox, et al.
JAMA Health Forum|January 13, 2023
Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019Lisa Clemans-Cope, Marni Epstein, Jessica Banthin, et al.
JAMA Internal Medicine|November 12, 2019
US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug ApprovalsSpencer Phillips Hey, Aaron S Kesselheim, Pranav Patel, et al.
JAMA Internal Medicine|September 29, 2018
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012Michael S Sinha, Mehdi Najafzadeh, Elizabeth K Rajasingh, et al.
Drug Safety|November 18, 2020
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) ProgramAmeet Sarpatwari, Mengdong He, Frazer A Tessema, et al.
JAMA Health Forum|November 22, 2023
Outcomes of the 340B Drug Pricing Program: A Scoping ReviewRyan P Knox, Junyi Wang, William B Feldman, et al.
Annals of Internal Medicine|July 4, 2017
High Generic Drug Prices and Market Competition: A Retrospective Cohort StudyChintan V Dave, Aaron S Kesselheim, Erin R Fox, et al.
American Heart Journal|March 3, 2015
Availability and utilization of cardiovascular fixed-dose combination drugs in the United StatesBo Wang, Niteesh K Choudhry, Joshua J Gagne, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Comparing supplemental indications for cancer drugs approved in the US and EUJelle Stoelinga, Lourens T Bloem, Massimiliano Russo, et al.
JAMA Internal Medicine|May 10, 2016
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in MassachusettsJames S Yeh, Jessica M Franklin, Jerry Avorn, et al.
Pageof 50